CannabisNewsBreaks

ThursdayFeb 15, 2018 11:18 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. Eyes Bright Future

The Green Organic Dutchman Holdings Ltd., also known as TGOD, remains confident that its commitment to its core values coupled with its unique approach to producing high quality, pharma-grade cannabis creates opportunities for the company, including potential joint ventures, licensing agreements and distribution partnerships. An article discussing the company’s bright future reads: “TGOD is setting the industry standard on several fronts, including environmental stewardship, natural resource sustainability and development of a consortium of world-class architectural, construction and utility management teams dedicated to responsible practices. As a Canadian licensed cannabis producer, TGOD prides itself on growing completely organic, pesticide-free, grown-in-live-soil cannabis.…

Continue Reading

MondayFeb 12, 2018 9:53 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (PVOTF) Issues Corporate Update

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) this morning issued a corporate update detailing its recent activity. Per the release, the company has had a “very active” start to the current calendar year, with its management team working to build a “differentiated” company in the cannabis sector by focusing on improving the cannabis consumer experience with scientifically-derived products. Pivot’s notable corporate highlights include its proposed acquisitions of ERS Holdings, LLC and Thrudermic, LLC; its ongoing product development efforts; its growing IP portfolio; its termination of a previously announced standstill agreement; out-licensing of its IP; and its engagement of an…

Continue Reading

FridayFeb 09, 2018 12:53 pm

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (PVOTF) Working on Delivery of Smokeless Cannabinoid Options

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) is focused on providing the health care marketplace with nutraceutical and pharmaceutical options for treating certain unmet needs. That extends to the medical cannabis industry, where the lack of a robust smokeless delivery system has troubled cannabinoid producers. An article discussing this reads: "Transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects. Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in…

Continue Reading

FridayFeb 09, 2018 9:46 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. Secures Financing Boost for Cannabis Facilities Expansion

Ultra-low cost organic cannabis producer The Green Organic Dutchman Holdings Ltd., also known as TGOD, has benefited from strategic investments by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) and other private placement financing, with its total financing climbing to $160 million. The Aurora investment in TGOD is accompanied by a supply agreement providing Aurora the right to purchase up to 20 percent of TGOD’s annual production of organic cannabis, and TGOD will receive additional services from Aurora and its subsidiary, Aurora Larssen Projects Inc. ("ALPS"). An article discussing this reads: “The investment fully funds the expansion of…

Continue Reading

TuesdayFeb 06, 2018 11:10 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement to Create Cannabis-infused Edibles Utilizing DehydraTECH™ Delivery Technology

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) recently entered an agreement with a cannabis-infused edibles manufacturer, Cannfections Group Inc. The agreement is expected to generate new cannabis-based edible products using Lexaria’s patented DehydraTECH™ delivery technology. An article discussing the agreement reads: “On January 25, 2018, Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced that it had entered into a seven-year agreement with Cannfections Group Inc. to provide its patented DehydraTECH™ technology for the development of a new range of cannabis-infused chocolates and gummies (http://cnw.fm/3oV1q). Cannfections is a new company, established by one of Canada’s leading chocolate manufacturers with over 85 years…

Continue Reading

MondayFeb 05, 2018 9:54 am

CannabisNewsBreaks – Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF) Subsidiary Approaching Pre-Sales Inspection

Canada’s first vertically-integrated cannabis brand house, Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF), through its DOJA Cannabis Ltd. subsidiary, this morning announced that it has received notification from Health Canada that its pre-sales inspection has been scheduled for Tuesday, February 13, 2018. Per the update, the pre-sales license inspection is the final step prior to the issuance of a sales license under the terms of the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). “As there are currently only 26 independent companies with cannabis sales licenses under the ACMPR in Canada, receiving confirmation of our Pre-Sales License Inspection from…

Continue Reading

ThursdayFeb 01, 2018 10:26 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Acquires Harvest Medicine Inc.

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has completed its acquisition of Harvest Medicine Inc. pursuant to the terms of a share purchase agreement dated January 31, 2018. Per the update, the acquisition was completed in consideration for, among other things, a cash payment of $1.5 million, the issuance of 1,056,338 common shares in the capital of the company and additional post-closing consideration related to certain performance milestones, including patient revenue and profitability metrics. Moving forward, Harvest Medicine will operate as a wholly-owned subsidiary of ABcann, but it will maintain its commitment to being an…

Continue Reading

WednesdayJan 31, 2018 2:58 pm

CannabisNewsBreaks – Organigram Holdings, Inc. (TSX.V: OGI) (OTCQB: OGRMF) Closes $115M Convertible Debenture Offering

Organigram Holdings (TSX.V: OGI) (OTCQB: OGRMF) this morning said that is has closed its short form prospectus offering of convertible unsecured debentures of the company on a bought deal basis, including the full exercise of the over-allotment option. A total of 115,000 convertible debentures were sold during the offering at a price of $1,000 each, resulting in gross proceeds of $115,000,000 to the company. Organigram intends to use the proceeds from the offering to support the strengthening of its stance within the Canadian and global cannabis markets. The securities have not been and will not be offered or sold within…

Continue Reading

TuesdayJan 30, 2018 1:50 pm

CannabisNewsBreaks – DOJA Cannabis Company (CSE: DOJA) (OTC: DJACF) Closes Merger with Tokyo Smoke, Launches Hiku Brands

DOJA Cannabis Company (CSE: DOJA) (OTC: DJACF) and Tokyo Smoke, a trademark and brand of TS Brandco Holdings, have successfully completed the previously announced merger of the two companies to create Hiku, Canada’s first retail and brand-focused licensed cannabis producer. Hiku has established a substantial national retail footprint and a growing portfolio of premium cannabis lifestyle brands including DOJA, Tokyo Smoke and Van der Pop. Common shares of Hiku are anticipated to begin trading on the Canadian Stock Exchange under the ticker symbol HIKU on January 31, 2018. To view the full press release, visit http://cnw.fm/ve5Iw About DOJA Cannabis Company…

Continue Reading

MondayJan 29, 2018 11:38 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential to Lower Medication Doses Using Advanced Drug Delivery

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has developed DehydraTECH™, a drug delivery platform that can be applied to various ingestible products such as foods, beverages, oral suspensions, tablets, capsules and more. An article discussing the company’s innovative drug delivery technology reads: “Lexaria’s DehydraTECH™ oral digestion technology is a ‘back office’ process that allows non-psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and nicotine to be absorbed at much higher rates. The company has been working with the National Research Council of Canada (“NRC”), an agency of the Canadian federal government, to explore the effects of its technology. Lexaria’s superior delivery system…

Continue Reading